Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma. uri icon

authors

  • Yang, Yuanquan
  • Hall, Evan
  • Thompson, John A
  • Yin, Ming
  • Sarah P. Psutka MD MS
  • Parikh, Anish B
  • Li, Mingjia
  • Collier, Katharine
  • Miah, Abdul
  • Mori, Sherry V
  • Hinkley, Megan
  • Tykodi, Scott S

publication date

  • January 1, 2022